[{"id":"a8e7704f-ff63-4ecb-8c62-ef6ed9442113","acronym":"","url":"https://clinicaltrials.gov/study/NCT04293094","created_at":"2021-01-18T20:49:54.746Z","updated_at":"2024-07-02T16:35:39.068Z","phase":"Phase 1","brief_title":"Study of AMG 650 in Adult Participants With Advanced Solid Tumors","source_id_and_acronym":"NCT04293094","lead_sponsor":"Volastra Therapeutics, Inc.","biomarkers":" HER-2 • ER • PGR","pipe":" | ","alterations":" HER-2 negative","tags":["HER-2 • ER • PGR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e sovilnesib (AMG 650)"],"overall_status":"Completed","enrollment":" Enrollment 66","initiation":"Initiation: 03/11/2020","start_date":" 03/11/2020","primary_txt":" Primary completion: 10/24/2022","primary_completion_date":" 10/24/2022","study_txt":" Completion: 02/15/2023","study_completion_date":" 02/15/2023","last_update_posted":"2023-08-24"}]